Skip to main content
logo
Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.925
-0.115 (-3.78%)
Aug 14, 2026, 11:16 AM EDT - Market open

Apyx Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.41-11.11-23.56-18.85-23.28-15.2
Depreciation & Amortization
0.780.660.60.690.890.9
Stock-Based Compensation
2.4224.015.116.75.09
Other Adjustments
1.622.042.152.250.630.6
Change in Receivables
-2.73-1.32-2.04-3.571.92-4.9
Changes in Inventories
-2.51-1.072.261.46-5.57-2.86
Changes in Accounts Payable
-0.680.36-0.060.030.071.15
Changes in Accrued Expenses
-1.360.21-2.270.28-1.213.4
Changes in Income Taxes Payable
---7.550.10.01
Changes in Other Operating Activities
-0.050.240.86-0.19-0.521.36
Operating Cash Flow
-10.13-8-18.05-5.25-20.28-10.45
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.92-1.11-0.72-0.53-1.01-0.72
Sale of Property, Plant & Equipment
---7.27--
Investing Cash Flow
-0.92-1.11-0.726.73-1.01-0.72

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---43.47--
Net Long-Term Debt Issued (Repaid)
---43.47--
Issuance of Common Stock
0.589.7970.090.370.07
Net Common Stock Issued (Repurchased)
0.589.7970.090.370.07
Other Financing Activities
-0.02-0.21-0.26-11.39-0.15-0.04
Financing Cash Flow
9.619.586.7532.170.220.02

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.24-0.470.11-0.190.40.1
Net Cash Flow
-1.68-0-11.9133.46-20.68-11.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.05-9.12-18.77-5.78-21.29-11.17
Free Cash Flow Growth
------
FCF Margin
-18.91%-17.25%-39.02%-11.05%-47.83%-23.03%
Free Cash Flow Per Share
-0.26-0.22-0.53-0.17-0.62-0.33
Levered Free Cash Flow
-13.37-11.94-22.834.04-30.44-11.93
Unlevered Free Cash Flow
-8.47-7.34-18.38-6.01-31.19-11.58
SEC Filings: 10-K · 10-Q